CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding CASI Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 2.74M | 2.25M | −498.9K (−18.2%) |
| Value | $5.93M | $2.65M | −$3.28M (−55.3%) |
New holders (3)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 36,246 | $42.8K | 0.00% |
| Two Sigma Securities, LLC | 11,599 | $13.7K | 0.00% |
| Citigroup Inc | 19 | $22 | 0.00% |
Sold out (2)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| West Paces Advisors Inc. | 100 | $216 |
| AdvisorNet Financial, Inc | 26 | $56 |